Supporting General Practitioners intensify medications for patients with poorly-controlled type 2 diabetes mellitus with computerised decision support: a cluster randomised controlled trial in Irish General Practice (the DECIDE study)

HRB Centre for Primary Care Research0 个研究点目标入组 134 人开始时间: 2017年7月26日最近更新: 2021年3月15日

适应症

试验速览

•GPs will be the target of the intervention and will be unit of randomisation. All GPs who are part of the HRB Clinical Trials Network will be eligible for inclusion.
•1. Only patients with poorly controlled T2DM will be targeted by the GP with the DECIDE intervention
•2. Patients must have a diagnosis of T2DM
•3. They must be aged over 18 years and less than 75, as there is less evidence about treatment intensification in patients aged above 75 years
•4. There is no validated cut-off which defines poor control of T2DM for targeted interventions. For the purposes of this study, the trialists have selected HbA1C or BP levels for which there would be consensus on the importance of intervention and treatment and have clinical face validity in terms of intervention. In the DECIDE study only patients with a HbA1c reading of 8.5% (70 mmol/mol) or above and/or a blood pressure reading over 150/95mmHg will be included
•5. Not all patients will be suitable for treatment intensification and individual decisions on treatment changes will be made by each patient’s GP.

发起方

HRB Centre for Primary Care Research